Trials / Completed
CompletedNCT01336647
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Phase 2 study to assess the safety and effectiveness of a product to treat children and adults with head lice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Group A - Low-Dose Ha44 0.37% w/w | Low Dose Ha44 Gel applied to scalp and hair for 10 minutes |
| DRUG | Group B - High Dose Ha44 Gel 0.74% w/w | High Dose Ha44 Gel applied to scalp and hair for 10 minutes |
| DRUG | Group C - Placebo | Placebo- vehicle Ha44 Gel without active ingredient applied to scalp and hair for 10 minutes |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-08-01
- Completion
- 2012-03-01
- First posted
- 2011-04-18
- Last updated
- 2020-04-29
- Results posted
- 2015-01-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01336647. Inclusion in this directory is not an endorsement.